Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, Dewey SL, Hitzemann R, Lieberman J.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10388-92.

2.

Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".

Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Dewey SL, Hitzemann R, Gifford AN, Pappas NR.

J Pharmacol Exp Ther. 1999 Jan;288(1):14-20.

3.

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.

Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM.

Synapse. 2002 Mar 1;43(3):181-7.

PMID:
11793423
4.

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE.

Nature. 1997 Apr 24;386(6627):827-30.

PMID:
9126740
5.

Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, Gifford A, Ding YS, Hitzemann R, Pappas N.

Life Sci. 1999;65(1):PL7-12.

PMID:
10403500
6.

Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.

Fowler JS, Volkow ND, Logan J, Gatley SJ, Pappas N, King P, Ding YS, Wang GJ.

Synapse. 1998 Feb;28(2):111-6.

PMID:
9450511
8.

Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.

Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding YS, Logan J.

Psychopharmacology (Berl). 1999 Sep 1;146(1):93-100.

PMID:
10485970
9.

Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.

Ding YS, Fowler JS, Volkow ND, Logan J, Gatley SJ, Sugano Y.

J Nucl Med. 1995 Dec;36(12):2298-305.

11.

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S.

Brain Res. 1999 Dec 4;849(1-2):85-96.

PMID:
10592290
12.

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL.

J Pharmacol Exp Ther. 2004 Jun;309(3):959-69. Epub 2004 Feb 24.

13.

The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects.

Volkow ND, Wang GJ, Fowler JS, Learned-Coughlin S, Yang J, Logan J, Schlyer D, Gatley JS, Wong C, Zhu W, Pappas N, Schueller M, Jayne M, Carter P, Warner D, Ding YS, Shea C, Xu Y.

Biol Psychiatry. 2005 Mar 15;57(6):640-6.

PMID:
15780851
14.
15.

Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.

Villemagne VL, Rothman RB, Yokoi F, Rice KC, Matecka D, Dannals RF, Wong DF.

Synapse. 1999 Apr;32(1):44-50.

PMID:
10188637
16.

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.

Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL.

Synapse. 2002 Jan;43(1):78-85.

PMID:
11746736
17.
18.
19.

A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.

Spencer TJ, Bonab AA, Dougherty DD, Martin J, McDonnell T, Fischman AJ.

Int J Mol Med. 2010 Feb;25(2):261-5.

PMID:
20043136
20.

A new PET ligand for the dopamine transporter: studies in the human brain.

Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Schlyer DJ, Pappas N.

J Nucl Med. 1995 Dec;36(12):2162-8.

Items per page

Supplemental Content

Write to the Help Desk